Atlas Trials

A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction

Clinical trial NCT04269083 · UNKNOWN

Trial details

NCT number
NCT04269083
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2020-05-24
Primary completion
2024-03-24
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.